Perioperative Chemotherapy vs Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG
Conditions: Gastric Cancer; Adenocarcinoma of the Esophagogastric Junction Interventions: Drug: Nivolumab; Drug: Ipilimumab; Drug: Relatlimab; Drug: Oxaliplatin; Drug: Docetaxel; Drug: 5-Fluorouracil; Drug: Folic acid Sponsors: Jan Ellermeier; GWT-TUD GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Eloxatin | Gastroenterology | Immunotherapy | Research | Taxotere | Yervoy